Covid-19 infection and death can be reduced with the help of rheumatoid arthritis drug along with other medications. The drug calms down immune response and prevents organ failure.
The SARS-CoV-2 is a single stranded RNA virus that causes Covid-19 infection. The virus mainly affects the upper respiratory tract and causes inflammation in the lungs leading to breathing problems. Severe infection can lead to death as it affects other major organs like the heart, brain, and kidneys.
New Antibodies can Prevent Viral Arthritis and Brain Infection
The two studies start from different points but arrive at the same conclusion that antibodies can prevent arthritis and brain infection caused alphaviruses in animals. This could help in creating a universal vaccine.
The two studies start from different points but arrive at the same conclusion that antibodies can prevent arthritis and brain infection caused alphaviruses in animals. This could help in creating a universal vaccine.
‘Rheumatoid arthritis drug along with standard care reduces the mortality in covid-19 patients.
’
Rheumatoid Arthritis Rheumatoid Arthritis is an autoimmune inflammatory disorder that causes inflammation in the joints. The symptoms of the condition are joint stiffness in the morning, swollen and tender joints, fatigue, fever, and loss of infection.
Patients who underwent COV-BARRIER trial were selected randomly and were administered with barictinib for 14 days along with the standard medications like remdesiver and dexomethosone. The results showed that
The drug had reduced the 28 day and 60 day mortality by 5%
The patients who were on mechanical ventilator (ECMO) showed greater signs of survival
Smoking Exposure Ups Risk of Rheumatoid Arthritis in Kids
Longitudinal study uncovers influence of passive exposure to parental smoking on adult-onset incident seropositive rheumatoid arthritis.
Longitudinal study uncovers influence of passive exposure to parental smoking on adult-onset incident seropositive rheumatoid arthritis.
According to Ely- professor at the Vanderbilt University Medical Center “Hospitalized patients with the SARS-CoV-2 infection (which causes COVID-19), often develop an intense hyperinflammatory state that can lead to dysfunction of multiple organs, including acute respiratory distress syndrome, septic shock and death,” “It is increasingly evident that treatment with baricitinib may help prevent death in some of the most critically ill COVID-19 patients, and that this class of medications represents an important treatment advance for this vulnerable group of patients in the constantly evolving pandemic,”
Advertisement
Platelet-rich Plasma Treatment Shows Efficacy in Arthritis Patients
New study assessed wearable technology and patient-reported outcomes to know the efficacy of platelet-rich plasma (PRP) treatment in osteoarthritis (OA).
New study assessed wearable technology and patient-reported outcomes to know the efficacy of platelet-rich plasma (PRP) treatment in osteoarthritis (OA).
Source: Medindia
Proper Management Of Arthritis Resolves its Burden During Pandemic
Prevention and self-care of arthritis are keys to bringing down the healthcare burden posed by the disease during a pandemic
Prevention and self-care of arthritis are keys to bringing down the healthcare burden posed by the disease during a pandemic
